Zynex to acquire NeuroDyne in bid to strengthen neurodiagnostic portfolio
This article was originally published in Clinica
Zynex Medical has signed a letter of intent to acquire neurodiagnostics specialist NeuroDyne Medical. The transaction, if completed, would give Zynex access to NeuroDyne's noninvasive technology for evaluating and treating neurological and muscular disorders. Financial details were not disclosed.